Litcius/Paper detail

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, Daniel R. Zwahlen, Tobias Hölscher, Philipp Gut, Bülent Polat, Guido Hildebrandt, Arndt‐Christian Müller, Ludwig Plaßwilm, Alexandros Papachristofilou, Corinne Schär, Marcin Sumila, Kathrin Zaugg, Matthias Gückenberger, Piet Ost, Christiane Reuter, Davide Giovanni Bosetti, Kaouthar Khanfir, Silvia Gómez, Peter Wust, George N. Thalmann, Daniel M. Aebersold, P. Gut, P. Thum, J. Collon, P.M. Putora, L. Plasswilm, M. Sassowsky, G.N. Thalmann, D.M. Aebersold, M. Sumila, H. Kranzbühler, K. Zaugg, A. Papachristofilou, F. Zimmermann, Y. Najafi, M. Brown, M. Guckenberger, S. Wuttke, C. Reuter, C. Oehler, D.R. Zwahlen, N.C. Azinwi, D.G. Bosetti, G. Pesce, I. Tacacs, S. Bodis, S. Gomez, K. Khanfir, F. Behrensmeier, K. Beer, P. Messer, T. Hölscher, M. Baumann, B. Polat, M. Flentje, V. Lewitzki, G. Hildebrandt, A.C. Müller, D. Zips, P. Ghadjar, P. Wust, V. Budach, U. Ganswindt, C. Belka, M. Pinkawa, M.J. Eble, K. Berkovic, M. Stuschke, P. Ost, F. Vandaele

2021European Urology114 citationsDOI

Topics & Concepts

MedicineProstatectomyProstate cancerClinical endpointUrologyHazard ratioHormonal therapyCommon Terminology Criteria for Adverse EventsRadiation therapyAdverse effectProstateRandomizationInternal medicineConfidence intervalRandomized controlled trialCancerProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and Applications